NASDAQ$TLRY

Tilray Brands Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Tilray's Q4 2021 performance was marked by a 25% increase in net revenue, driven by cannabis revenue growth and strategic acquisitions, alongside a significant improvement in net income and adjusted EBITDA.

Tilray reported a 25% increase in net revenue to $142.2 million for the fourth quarter of fiscal year 2021, driven by a 36% increase in cannabis revenue and contributions from beverage alcohol and wellness segments. The company achieved a net income of $33.6 million, a significant improvement from the prior year's net loss, and adjusted EBITDA increased by 285% to $12.3 million. Tilray also reported positive free cash flow of $3.3 million and has achieved $35 million in synergies from the business combination with Aphria.

  • Net revenue increased by 25% to $142.2 million, driven by growth in cannabis, beverage alcohol, and wellness segments.
  • Net income was $33.6 million, a significant improvement compared to the prior year's net loss of $84.3 million.
  • Adjusted EBITDA increased by 285% to $12.3 million, marking the ninth consecutive quarter of positive adjusted EBITDA.
  • Free cash flow was $3.3 million, compared to ($28.3) million in the prior year quarter.

Headline financials

Total Revenue

$142M

Previous: $56.6M+151.5%
EPS (adj)

$0.27

Previous: -$0.45+160.0%
Adjusted EBITDA

$12.3M

Previous: $3.21M+283.6%
Free Cash Flow

$3.34M

No prior period
Net Income

$33.6M

Previous: -$103M+132.8%
Operating Income

-$73.7M

Previous: -$104M+29.1%
Gross Profit

$22.5M

Previous: $96.1M-76.6%
Cash & Equivalents

$488M

Previous: $361M+35.4%
Total Assets

$6.03B

Previous: $1.74B+246.7%
Stock-Based Comp

$5.94M

Previous: $18.1M-67.2%

Revenue & EPS history

Tilray · Revenue · Quarterly

$142M

Q4 2021+151.5%vs Q4 2020
Beat estimate in 7 of 15 quarters(47%)
ActualEstimate

Revenue by segment

Tilray · $142M total across 4 segments · Q4 2021

  • Distribution
    $66.8M-9.7%
  • Cannabis
    $53.7M+35.7%
  • Beverage
    $15.9M
  • Wellness
    $5.79M

Forward guidance

The Company expects to deliver significant cost synergies totaling approximately $80 million within eighteen months of closing the Aphria Tilray business combination and plans to achieve cost synergies in the key areas of cultivation and production, cannabis and product purchasing, sales, and marketing, and corporate expenses. To date, the Company has achieved $35 million in synergies.

Tailwinds

  • Tilray has been gaining market share nationally in Canada month-over-month since April 2021.
  • SweetWater Brewing Company, launched of 420 Imperial IPA, the first line extension off of its flagship 420 brand.
  • SweetWater Brewing Company announced its West Coast expansion including a new Colorado Brewery and the opening of SweetWater Mountain Taphouse at Denver International Airport.
  • Tilray announced the completion and shipment of the first successful EU GMP-certified medical cannabis harvest grown in Germany for German distribution.
  • Tilray announced the first cross-brand product collaboration between Canadian craft-cannabis brand Broken Coast and SweetWater to launch U.S. distribution of “Broken Coast BC Lager” and introduce the cannabis brand to consumers across the country.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

-2.1%

Avg return

Earnings day

-4.2%

Avg return

5 days after

-3.5%

Avg return

30 days after

34%

11 / 32 earnings

Positive

+27.4%

Q4 2023

Best reaction

-22.0%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026-2.9%-9.2%
Q2 2026+0.2%+8.4%-17.0%
Q1 2026+21.2%-7.0%-27.9%
Q3 2025-21.2%-15.5%-24.1%
Q2 2025-13.9%-13.9%-27.0%
Q1 2025+0.0%-3.7%-8.6%
Q4 2024+9.8%+1.6%-7.1%
Q3 2024-22.0%-29.7%-23.6%
Q2 2024-14.5%-20.1%-19.2%
Q1 2024-5.4%-9.4%-14.3%
Q4 2023+27.4%+50.6%+39.3%
Q3 2023-3.1%-8.8%+5.8%
Q2 2023-5.4%+7.5%+2.7%
Q1 2023-21.3%-21.0%-2.3%
Q4 2022+12.0%+19.6%+17.5%
Q3 2022-7.8%-9.4%-32.6%
Q2 2022+15.0%+6.9%+7.8%
Q1 2022-2.8%-4.7%-0.8%
Q4 2021+21.1%+14.8%+5.4%
Q3 2021+1.4%+0.1%-16.8%
Q4 2020-21.7%-24.1%-26.8%
Q2 2021+4.3%+10.2%+109.7%
Q3 2020-13.5%-20.6%-17.8%
Q2 2020-7.1%-2.8%-24.3%
Q1 2020-4.0%-0.1%+24.6%
Q4 2019-9.8%-30.6%-59.1%
Q3 2019-4.5%-9.1%-13.6%
Q2 2019-8.1%-26.3%-28.0%
Q1 2019+5.2%-1.7%-12.4%
Q4 2018-3.7%-7.4%-30.1%
Q3 2018-9.8%-2.6%-33.4%
Q2 2018+16.3%+22.0%+145.7%
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2012
Q4 2012
Q3 2011
Q2 2011

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro